ANNX · Annexon Inc
United States · RS rating 35 · As of 2026-11-03
| Price | 4.19 USD |
|---|---|
| 1-day change | +6.3% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 55 / 29 / 77 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 15 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +24.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.8% |
| Market cap (USD) | $972.5M |